A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

NCT00824473 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

506

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Placebo
DRUG: 0.15% azelastine hydrochloride

Sponsor

Meda Pharmaceuticals